World’s First Minimally Invasive Non-blood Contacting
Cardiac Assist Device to Treat Acute Heart Failure.

With a lead investment from Wellcome Trust, CorInnova is developing a minimally invasive, non-blood contacting cardiac assist device for acute heart failure treatment.  The device is intended to initially treat the large and fast-growing short-term cardiac assist market (up to 7 days’ use) and will expand this market up to 50% to a $6B addressable market by treating the 40% of patients who cannot use, or are unsuitable for, existing cardiac assist devices. The device is collapsible allowing it to be delivered and secured to the heart in a minimally invasive manner. The device conforms to the heart’s surface, and gently compresses the heart to increase cardiac output using an external pneumatic driver that operates in synchrony with the heartbeat.

The device increases cardiac output without touching the blood, thereby eliminating the risk of thrombosis and stroke due to device blood contact, the need for anti-coagulants, the risk of bleeding, and the risk of kidney dysfunction or damage.

News & Press Releases
Awards, Recognition, Investments

_____

IMG_1B5229567181-1.jpeg

CorInnova invited to speak at CSI D-HF Device Therapies for Heart Failure in Frankfurt

IMG_83B457CF6CB7-1.jpeg

CorInnova wins “Most Promising Life Science Company” award from Rice Alliance for Technology and Entrepreneurship at Texas Life Science Forum

_____

MedTech Inn logo.png
Welcomme sm bw.jpeg
JLABS.png
TechFW.png
AngelMD
NSF logo_nsf2.jpg

2020, 2019 National Science Foundation Grant Awards

ACA box logo.png
TMC
MedCity logo.png
MedTech Inn logo.png

2019 Finalist Medtech Innovator Competition West Coast Round

Screen Shot 2017-10-16 at 5.34.54 PM.png
TMC Venture Logo.png
gBETAlogo.png
RESI Small logo.jpeg
HTA Logo.png

2018 Health Tech Austin Medical Device Showcase Competition

sharktank.jpg
Screen Shot 2017-10-16 at 5.38.47 PM.png
Screen Shot 2017-10-16 at 5.37.21 PM.png
TCT CRF logo.jpg

TCT 2016 Interventional Innovation and Best Technical Concepts in Interventional Heart Failure

US Pat Seal.png

US Patent Office 15 Granted Patents

Screen Shot 2017-10-16 at 5.52.51 PM.png

NIH STTR Fast Track Phase I/II Grant Award

Investments

TETF.jpg
TMC Venture Logo.png

Texas Emerging Technology Fund

Texas Medical Center

TMC Venture Fund

HAN logo.png
K4 Logo.png

Houston Angel Network

Keiretsu Forum

SCAN logo.jpg
Cowtown logo.jpg

South Coast Angel Network

Cowtown Angels

Acadiana logo.jpg

Acadiana Angels

Kyto logo.jpg

KYTO Technology

& Life Sciences

HBSAANY.jpg

Harvard Business School

Alumni Angels of Greater

New York

AVP FastTrak Fund

None of the statements or information contained on our website is an offer to buy or sell our securities.  Offers to buy or sell our securities are made only pursuant to separate formal legal agreements. Nor should you make any investment decision based on the information on our website, but solely on that information contained in such legal agreements.